These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26593296)

  • 21. Assessing liver fibrosis.
    Castera L
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):541-52. PubMed ID: 19072402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non invasive tools for the diagnosis of liver cirrhosis.
    Soresi M; Giannitrapani L; Cervello M; Licata A; Montalto G
    World J Gastroenterol; 2014 Dec; 20(48):18131-50. PubMed ID: 25561782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The management of autoimmunity in patients with cholestatic liver diseases.
    Ali AH; Carey EJ; Lindor KD
    Expert Rev Gastroenterol Hepatol; 2016; 10(1):73-91. PubMed ID: 26523975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-invasive diagnosis of advanced fibrosis and cirrhosis.
    Sharma S; Khalili K; Nguyen GC
    World J Gastroenterol; 2014 Dec; 20(45):16820-30. PubMed ID: 25492996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy?
    Castera L; Bedossa P
    Liver Int; 2011 Jan; 31 Suppl 1():13-7. PubMed ID: 21205132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-invasive diagnosis of liver fibrosis and cirrhosis.
    Lurie Y; Webb M; Cytter-Kuint R; Shteingart S; Lederkremer GZ
    World J Gastroenterol; 2015 Nov; 21(41):11567-83. PubMed ID: 26556987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in Cholestatic Liver Diseases.
    Levy C
    Clin Liver Dis; 2016 Feb; 20(1):xiii-xiv. PubMed ID: 26593300
    [No Abstract]   [Full Text] [Related]  

  • 28. Noninvasive diagnosis of liver fibrosis: utility of data mining of both ultrasound elastography and serological findings to construct a decision tree.
    Yada N; Kudo M; Kawada N; Sato S; Osaki Y; Ishikawa A; Miyoshi H; Sakamoto M; Kage M; Nakashima O; Tonomura A
    Oncology; 2014; 87 Suppl 1():63-72. PubMed ID: 25427735
    [TBL] [Abstract][Full Text] [Related]  

  • 29.  Noninvasive markers of fibrosis: key concepts for improving accuracy in daily clinical practice.
    Duarte-Rojo A; Altamirano JT; Feld JJ
    Ann Hepatol; 2012; 11(4):426-39. PubMed ID: 22700624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporation of Noninvasive Measures of Liver Fibrosis Into Clinical Practice: Diagnosis and Prognosis.
    Asrani SK
    Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2190-204. PubMed ID: 26226095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrosis distribution in explanted cirrhotic livers.
    Hall A; Germani G; Isgrò G; Burroughs AK; Dhillon AP
    Histopathology; 2012 Jan; 60(2):270-7. PubMed ID: 22211285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
    Hay JE
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive methods to assess liver disease in patients with hepatitis B or C.
    Castera L
    Gastroenterology; 2012 May; 142(6):1293-1302.e4. PubMed ID: 22537436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of real-time strain elastography, transient elastography, and aspartate-to-platelet ratio index in the assessment of fibrosis in chronic hepatitis C.
    Ferraioli G; Tinelli C; Malfitano A; Dal Bello B; Filice G; Filice C; ; Above E; Barbarini G; Brunetti E; Calderon W; Di Gregorio M; Lissandrin R; Ludovisi S; Maiocchi L; Michelone G; Mondelli M; Patruno SF; Perretti A; Poma G; Sacchi P; Zaramella M; Zicchetti M
    AJR Am J Roentgenol; 2012 Jul; 199(1):19-25. PubMed ID: 22733889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding and Treating Fatigue in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis.
    Jopson L; Dyson JK; Jones DE
    Clin Liver Dis; 2016 Feb; 20(1):131-42. PubMed ID: 26593295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
    Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
    Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acoustic radiation force impulse elastography as compared to transient elastography and liver biopsy in patients with chronic hepatopathies.
    Sporea I; Sirli RL; Deleanu A; Popescu A; Focsa M; Danila M; Tudora A
    Ultraschall Med; 2011 Jan; 32 Suppl 1():S46-52. PubMed ID: 20603783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recognizing primary biliary cirrhosis and primary sclerosing cholangitis.
    Buckley SE; DiPalma JA
    Am Fam Physician; 1996 Jan; 53(1):195-200. PubMed ID: 8546046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers of liver fibrosis.
    Suk KT; Kim DY; Sohn KM; Kim DJ
    Adv Clin Chem; 2013; 62():33-122. PubMed ID: 24772665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of liver biopsy in the era of direct-acting antivirals.
    Gonzalez HC; Jafri SM; Gordon SC
    Curr Gastroenterol Rep; 2013 Feb; 15(2):307. PubMed ID: 23319086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.